1 results match your criteria: "France.7 Groupe Hospitalier Henri Mondor[Affiliation]"
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
Transplantation
October 2016
1 Hôpital Pasteur, Nice, France.2 Hôpital Saint Eloi, Montpellier, France.3 CHU Nantes, Nantes, France.4 Hôpital Rangueil, Toulouse, France.5 Hôpital Necker, Paris, France.6 Hôpital de Jour, Villejuif, France.7 Groupe Hospitalier Henri Mondor, Créteil, France.8 CHU Bordeaux, Bordeaux, France.9 Hôpital Europeen Georges Pompidou, Paris, France.10 CHU Amiens-Picardie, Amiens, France.11 Mapi, Lyon, France.12 Hôpital Claude Huriez, Lille, France.13 Hôpital d'adultes de Brabois, Vandoeuvre Les Nancy, France.
Background: Adherence to immunosuppressive treatments is a major concern in transplanted patients.
Methods: This 6-month French observational, longitudinal, prospective study aimed to assess patient adherence to and acceptance of once-daily tacrolimus (Advagraf) initiation in kidney and liver transplant recipients. Data from 1106 patients initiating once-daily tacrolimus during posttransplant follow-up were analyzed.